Keywords: Small Animals, fMRI (resting state), Cancer pain, Drug discovery
Motivation: Chronic pain significantly interferes with daily life in cancer patients. However, the mechanisms of pain responses and neurotransmission circuits in the brain remain elusive.
Goal(s): The aim is to develop a diagnostic MRI method to monitor the cancer pain state and the state transition induced by analgesic candidates.
Approach: Tumor-bearing cancer pain model mice were monitored by resting-state fMRI, and the pharmacological effect was evaluated for a newly developed chemokine signal-regulating agent.
Results: Pain-related brain regions were significantly identified in stronger functional connective networks, while functional connectivity was suppressed after administration of the chemokine signal-regulating agent.
Impact: The pain state transition induced by the analgesic agent in the tumor-bearing mouse brain was characterized by resting-state fMRI. Our experimental system is useful for the evaluation of new analgesic candidates in nonclinical and, expectantly, clinical studies.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords